Genentech, Inc.

Phone: +16502251000

Fax: +1 (650) 225-6000

E-mail: https://www.gene.com/contact-us/email-us

Web: https://www.gene.com/

Type	Private ( Independent subsidiary)
Industry	Biotechnology
Founded	1976 (1976)
Headquarters	South San Francisco, California, United States
Key people	Alexander Hardy (CEO) Ed Harrington Sandra J. Horning, M.D. Michael D. Varney Stephen Williams Ph.D. Sean Johnston Severin Schwan (Chairman of Genentech Board of Directors, CEO of Roche Group) Anna Batt Ph.D. Aviv Regev
Products	Avastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Polivy, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax
Revenue	26.4 billion (2020)
Number of employees	13,539 (July 2021)
Parent	Hoffmann-La Roche
Website	www.gene.com

Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.

As of July 2021, Genentech employed 13,539 people.

For detailed contact information visit location pages below.